GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.000099 (9,900.00%)
At close: Aug 10, 2026
GlobeImmune Market Cap
GlobeImmune has a market cap or net worth of $575 as of September 4, 2026.
Market Cap
575.00
Enterprise Value
n/a
Revenue
6.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since July 2, 2014, GlobeImmune's market cap has decreased from 60.99M to 575.00, a decrease of -100.00%. That is a compound annual growth rate of -61.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 575.00 | - |
| Dec 31, 2025 | 575.00 | 9,483.33% |
| Dec 12, 2024 | 6.00 | -99.85% |
| Dec 30, 2022 | 4.03K | 600.17% |
| Dec 31, 2021 | 575.00 | -99.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteonomix | 791.00 |
| Pathfinder Cell Therapy | 667.00 |
| Amarantus BioScience Holdings | 630.00 |
| Alzex Neuropharma | 602.00 |
| Adynxx | 581.00 |
| Mera Pharmaceuticals | 537.00 |
| Innovation Pharmaceuticals | 529.00 |
| Tetra Bio-Pharma | 516.00 |